

Improving the health of our patients through groundbreaking clinical research
The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.
Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.
Qualifications:
Duration: 54 weeks
Location: Hackensack, NJ
Compensation: Up to $1,100 if all study visits are completed
To participate Please click here.
Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.
Qualifications:
Duration: Up to 20 weeks
Location: Hackensack, NJ
Compensation: Up to $630 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Purpose: The purpose of this trial is to evaluate the effect of trifarotene 50 μg/g cream versus vehicle cream on the risk of formation of atrophic acne scars in facial acne subjects. This is a randomized, double-blind, vehicle-controlled clinical study using a split-face design for intra-individual comparison (right half-face versus left half-face).
Qualifications:
Duration: Up to 24 weeks
Location: Hackensack, NJ
Compensation: Up to $1,450
Interested in participating in our clinical research study? Please click here.
Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.
Qualifications:
Duration: Up to 7 months
Location: Hackensack, NJ
Compensation: Up to $650
Interested in participating in our clinical research study? Please click here.
Purpose: The purpose of this investigation is to evaluate the safety and efficacy of the Cutera® 1726 nm laser system for the treatment of moderate to severe acne. Subjects will receive 3 laser treatments at 4-week intervals. Follow-up visits will occur at approximately 7 days post each treatment (via phone) and at 12-, 26- and 52-weeks post third treatment.
Qualifications:
Duration: Approximately 17 months
Location: Hackensack, NJ
Compensation: Up to $275 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Interested in participating in our clinical research study? Please click here.
To learn more contact: Diana Aranzazu, [email protected], 609-219-5621
All Rights Reserved. Web Design & Internet Marketing by Studio III
The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.
New safety policies for patients:
New safety policies for office & staff: